Clinical trial
Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabin/Cisplatin Plus Bevacizumab
NCT00536640 is registered in ClinicalTrials.gov with Aktion Bronchialkarzinom e.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabin/Cisplatin Plus Bevacizumab
- Lead sponsor
- Aktion Bronchialkarzinom e.V.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- May 31, 2012
- Enrollment
- 224 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.